Center-Authored Papers

Filters: Author is Ferrari, Guido  [Clear All Filters]
2008
Gasper-Smith N, Crossman DM, Whitesides JF, Mensali N, Ottinger JS, Plonk SG, Moody AM, Ferrari G, Weinhold KJ, Miller SE et al..  2008.  Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design.. Journal of virology. 82(15):7700-10. Abstract
2009
Spearman P, Kalams S, Elizaga M, Metch B, Chiu Y-L, Allen M, Weinhold KJ, Ferrari G, Parker SD, McElrath MJ et al..  2009.  Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trial.. Vaccine. 27(2):243-9. Abstract
2010
Weinberg A, Song LY, Wilkening CL, Fenton T, Hural J, Louzao R, Ferrari G, Etter PE, Berrong M, Canniff JD et al..  2010.  Optimization of storage and shipment of cryopreserved peripheral blood mononuclear cells from HIV-infected and uninfected individuals for ELISPOT assays.. Journal of immunological methods. 363(1):42-50. Abstract
2011
Ferrari G, Korber B, Goonetilleke N, Liu MKP, Turnbull EL, Salazar-Gonzalez JF, Hawkins N, Self SG, Watson S, Betts MR et al..  2011.  Relationship between functional profile of HIV-1 specific CD8 T cells and epitope variability with the selection of escape mutants in acute HIV-1 infection.. PLoS pathogens. 7(2):e1001273. Abstract
Pollara J, Hart L, Brewer F, Pickeral J, Packard BZ, Hoxie JA, Komoriya A, Ochsenbauer C, Kappes JC, Roederer M et al..  2011.  High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responses.. Cytometry. Part A : the journal of the International Society for Analytical Cytology. 79(8):603-12. Abstract
Keefer MC, Frey SE, Elizaga M, Metch B, De Rosa SC, Barroso PF, Tomaras G, Cardinali M, Goepfert P, Kalichman A et al..  2011.  A phase I trial of preventive HIV vaccination with heterologous poxviral-vectors containing matching HIV-1 inserts in healthy HIV-uninfected subjects.. Vaccine. 29(10):1948-58. Abstract
2012
Haynes BF, Gilbert PB, McElrath MJ, Zolla-Pazner S, Tomaras GD, Alam MS, Evans DT, Montefiori DC, Karnasuta C, Sutthent R et al..  2012.  Immune-correlates analysis of an HIV-1 vaccine efficacy trial.. The New England journal of medicine. 366(14):1275-86. Abstract
Bonsignori M, Pollara J, Moody AM, Alpert MD, Chen X, Hwang K-K, Gilbert PB, Huang Y, Gurley TC, Kozink DM et al..  2012.  Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene Family.. Journal of virology. 86(21):11521-32. Abstract
Fukazawa Y, Park H, Cameron MJ, Lefebvre F, Lum R, Coombes N, Mahyari E, Hagen SI, Bae JY, Iii MDR et al..  2012.  Lymph node T cell responses predict the efficacy of live attenuated SIV vaccines.. Nature medicine. 18(11):1673-81. Abstract
2013
Liu MKP, Hawkins N, Ritchie AJ, Ganusov VV, Whale V, Brackenridge S, Li H, Pavlicek JW, Cai F, Rose-Abrahams M et al..  2013.  Vertical T cell immunodominance and epitope entropy determine HIV-1 escape.. The Journal of clinical investigation. 123(1):380-93. Abstract
Tomaras GD, Ferrari G, Shen X, Alam MS, Liao H-X, Pollara J, Bonsignori M, Moody AM, Fong Y, Chen X et al..  2013.  Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG.. Proceedings of the National Academy of Sciences of the United States of America. 110(22):9019-24. Abstract
Liu P, Yates NL, Shen X, Bonsignori M, Moody AM, Liao H-X, Fong Y, Alam MS, Overman GR, Denny T et al..  2013.  Infectious Virion Capture by HIV-1 gp120 Specific IgG from RV144 Vaccinees.. Journal of virology. Abstract
2014
Sambor A, Garcia A, Berrong M, Pickeral J, Brown S, Rountree W, Sanchez A, Pollara J, Frahm N, Keinonen S et al..  2014.  Establishment and maintenance of a PBMC repository for functional cellular studies in support of clinical vaccine trials.. Journal of immunological methods. Abstract
Yates NL, Liao H-X, Fong Y, DeCamp A, Vandergrift NA, Williams WT, Alam MS, Ferrari G, Yang Z-Y, Seaton KE et al..  2014.  Vaccine-Induced Env V1-V2 IgG3 Correlates with Lower HIV-1 Infection Risk and Declines Soon After Vaccination.. Science translational medicine. 6(228):228ra39. Abstract
Sanchez AM, Rountree W, Berrong M, Garcia A, Schuetz A, Cox J, Frahm N, Manak M, Sarzotti-Kelsoe M, D'Souza PM et al..  2014.  The External Quality Assurance Oversight Laboratory (EQAPOL) proficiency program for IFN-gamma enzyme-linked immunospot (IFN-γ ELISpot) assay.. Journal of immunological methods. Abstract
2015
Kvistborg P, Gouttefangeas C, Aghaeepour N, Cazaly A, Chattopadhyay PK, Chan C, Eckl J, Finak G, Hadrup SR, Maecker HT et al..  2015.  Thinking outside the gate: single-cell assessments in multiple dimensions.. Immunity. 42(4):591-2.
Hancock G, Yang H, Yorke E, Wainwright E, Bourne V, Frisbee A, Payne TL, Berrong M, Ferrari G, Chopera D et al..  2015.  Identification of effective subdominant anti-HIV-1 CD8+ T cells within entire post-infection and post-vaccination immune responses.. PLoS pathogens. 11(2):e1004658. Abstract
Prentice HA, Tomaras GD, Geraghty DE, Apps R, Fong Y, Ehrenberg PK, Rolland M, Kijak GH, Krebs SJ, Nelson W et al..  2015.  HLA class II genes modulate vaccine-induced antibody responses to affect HIV-1 acquisition.. Science translational medicine. 7(296):296ra112. Abstract
Williams WB, Liao H-X, Moody AM, Kepler TB, Alam MS, Gao F, Wiehe K, Trama AM, Jones K, Zhang R et al..  2015.  Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies.. Science (New York, N.Y.). Abstract
García-Arriaza J, Perdiguero B, Heeney J, Seaman M, Montefiori DC, Labranche C, Yates NL, Shen X, Tomaras GD, Ferrari G et al..  2015.  Head-to-head comparison of poxvirus NYVAC and ALVAC vectors expressing identical HIV-1 clade C immunogens in prime/boost combination with Env protein in non-human primates.. Journal of virology. Abstract
Permar SR, Fong Y, Vandergrift N, Fouda GG, Gilbert P, Parks R, Jaeger FH, Pollara J, Martelli A, Liebl BE et al..  2015.  Maternal HIV-1 envelope-specific antibody responses and reduced risk of perinatal transmission.. The Journal of clinical investigation. Abstract
2016
Cosgrove CA, Lacey CJ, Cope AV, Bartolf A, Morris G, Yan C, Baden S, Cole T, Carter D, Brodnicki E et al..  2016.  Comparative Immunogenicity of HIV-1 gp140 Vaccine Delivered by Parenteral, and Mucosal Routes in Female Volunteers; MUCOVAC2, A Randomized Two Centre Study.. PloS one. 11(5):e0152038. Abstract
Zurawski G, Zurawski S, Flamar A-L, Richert L, Wagner R, Tomaras GD, Montefiori DC, Roederer M, Ferrari G, Lacabaratz C et al..  2016.  Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques.. PloS one. 11(4):e0153484. Abstract
Astronomo RD, Santra S, Ballweber-Fleming L, Westerberg KG, Mach L, Hensley-McBain T, Sutherland L, Mildenberg B, Morton G, Yates NL et al..  2016.  Neutralization Takes Precedence Over IgG or IgA Isotype-related Functions in Mucosal HIV-1 Antibody-mediated Protection.. EBioMedicine. 14:97-111. Abstract
Huang Y, Ferrari G, Alter G, Forthal DN, Kappes JC, Lewis GK, Love CJ, Borate B, Harris L, Greene K et al..  2016.  Diversity of Antiviral IgG Effector Activities Observed in HIV-Infected and Vaccinated Subjects.. Journal of immunology (Baltimore, Md. : 1950). 197(12):4603-4612. Abstract